Efficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)

NCT02637960 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

432

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia

Interventions

DRUG: Fedovapagon 2 mg
DRUG: Placebo

Sponsor

Vantia Ltd